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ABSTRACT 21 
Dendritic cells (DC) are one of the earliest targets of HIV-1 infection acting as a 22 
‘Trojan Horse’, concealing the virus from the innate immune system and delivering it 23 
to T-cells via virological synapses (VS).  To explicate how the virus is trafficked 24 
through the cell to the VS and evades degradation, a high-throughput siRNA screen 25 
targeting membrane trafficking proteins was performed in monocyte-derived 26 
dendritic cells (MDDC). We identified several proteins including BIN-1 and RAB7L1 27 
that share common roles in transport from endosomal compartments. Depletion of 28 
target proteins resulted in an accumulation of virus in intracellular compartments 29 
and significantly reduced viral trans-infection via the VS. By targeting endocytic 30 
trafficking and retromer recycling to the plasma membrane, we were able to reduce 31 
the virus’s ability to accumulate at budding microdomains and the VS.  Thus, we 32 
identify key genes involved in a pathway within DC that is exploited by HIV-1 to 33 
traffic to the VS. 34 
 35 
IMPORTANCE 36 
The lentivirus Human Immunodeficiency Virus (HIV) targets and destroys CD4+ T-37 
cells, leaving the host vulnerable to life-threatening opportunistic infections 38 
associated with Acquired Immunodeficiency Syndrome (AIDS). Dendritic cells form a 39 
Virological synapse (VS) with CD4+ T-cells, enabling the efficient transfer of virus 40 
between the two cells. We have identified cellular factors that are critical in the 41 
induction of the VS. We show that ARF1, BIN1, RAB7L1 and RAB8A are important 42 
regulators of HIV-1 trafficking to the VS and therefore infection of CD4+ T-cells. We 43 
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found these cellular factors to be essential for endosomal protein trafficking and 44 
formation of the VS, depletion of target proteins prevented virus trafficking to the 45 
plasma membrane by retaining virus in intracellular vesicles. Identification of key 46 
regulators in HIV-1 trans-infection between DC and CD4+ T-cells has the potential for 47 
development of targeted therapy to reduce trans-infection of HIV-1 in vivo. 48 
 49 
INTRODUCTION 50 
Dendritic cells (DC) are key antigen-presenting cells that provide an 51 
important link between innate and adaptive immune systems, activating T-cells 52 
(reviewed in (1, 2)). Although HIV-1 is able to replicate in DC, the process is 53 
inefficient and produces low levels of infectious virus (3-8). However, DCs are able to 54 
transfer intact viral particles to target T-cells via a virological synapse (VS) by a 55 
process termed trans-infection (9), contributing to the spread of infection in vivo (10, 56 
11).  57 
HIV-1 trans-infection has been shown to depend on the ability of the virus to 58 
‘surf’ along the surface of the DC via actin rich dendrites, to promote trans-infection 59 
(12-14).  Several studies conducted in macrophages and DC located virus 60 
sequestered into plasma membrane invaginated compartments from which viral 61 
particles are released at the VS (15-18). These compartments are thought to be 62 
surface accessible (15), however there is evidence of a population becoming isolated 63 
from the cell surface (16). It is established in macrophages and DC that these surface 64 
accessible compartments may have complex morphologies that require membrane 65 
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trafficking regulation, such as the virus containing compartments found in 66 
macrophages (17). 67 
In contrast, cis-infection of DC is limited by the host restriction factor 68 
SAMHD1, a dinucleotide triphosphate (dNTP) hydrolase that blocks reverse 69 
transcription of viral DNA (19-24). In addition, viral cytosolic DNA is sensed by cGAS, 70 
a GMP-AMP synthase that induces an interferon type I response in DC (25-27) 71 
restricting productive viral replication. 72 
It has been previously reported that HIV-1 virus enters the cell through the 73 
endolysosomal pathway with evidence supporting roles for clathrin-mediated 74 
endocytosis (4, 28, 29), receptor-mediated endocytosis (30, 31) and 75 
macropinocytosis (32).  However, at later time points virus accumulates in virus 76 
containing compartments, rich in tetraspanins such as CD81 that are continuous with 77 
the plasma membrane (4, 15, 17). More recent studies identified the importance of 78 
tetraspanin 7 (TSPAN7) and dynamin 2 (DNM2) in maintaining viral particles on 79 
dendrites and promoting efficient viral transfer. Disruption of these targets led to 80 
sequestration of virus in intracellular vesicles and a reduction in viral transfer (13).  81 
To elucidate the role of membrane trafficking in the capture and trafficking of 82 
the virus through DC to the VS, we performed a high-throughput siRNA screen 83 
targeting membrane trafficking proteins. Our results identified proteins involved in 84 
vesicle trafficking between early endosomes, the trans-Golgi network (TGN) and the 85 
plasma membrane that reduce transfer of HIV-1 from DC to T-cells. We show that 86 
HIV-1 is dependent on a functioning endocytic pathway, disruption of which results 87 
in an accumulation of virus in intracellular vesicles, blocking trafficking of the virus to 88 
the virological synapse. 89 
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 90 
RESULTS 91 
siRNA membrane trafficking library identified genes involved in HIV-1 trans-92 
infection between DC and T-cells. 93 
To identify the cellular trafficking pathways involved in the transfer of HIV-1 94 
in trans-infection from DC to CD4+ T-cells, a siRNA library targeting 140 membrane 95 
trafficking genes was utilised. SMARTpool siRNA were transfected into MDDC 48 96 
hours before infection with full-length CXCR4-tropic HIV-1 (R9) and co-cultured with 97 
SUPT1 cells at 1:1 ratio. HIV-1 infected SUP-T1 cells were analysed by flow cytometry 98 
48 hours later.  No infection was detected in SUP-T1 cells inoculated with a HIV-1 99 
fusion-mutant control (Figure 1a). Non-target siRNA were used to compare infection 100 
levels and showed < 20% variation between replicates (Z score = 1.5 s.d.), therefore 101 
the lower assay cut-off point was set at 20%. 102 
In the primary screen, the knockdown of 16 genes induced a reduction in 103 
HIV-1 trans-infection greater than or equal to 20%, whereas 25 genes showed an 104 
increase in viral trans-infection by over 50% (Figure 1b). The primary Hits were 105 
reproduced in two donors using autologous CD4+ T-cells activated with IL-2 and PHA. 106 
Nine Hits showed a reproducible reduction in HIV-1 transfer: AP1M1, AMPH1, ARF1, 107 
BIN1, EPN3, PAK1, RAB7L1, RAB8A and WASF1 (Figure 1c).  Hits that resulted in an 108 
increase in HIV-1 transfer included AP2M1, CLTB, CLTC, EPS15, GRB2, HIP1, RAB1A, 109 
RAB2, ROCK1, VAV2, EFS, MAPK8IP2, DNM3 (Figure 1d).   110 
Efficient HIV-1 trans-infection requires vesicle trafficking at the plasma membrane 111 
To understand potential relationships between the genes selected in the 112 
siRNA screen, gene-annotation enrichment analysis was used to identify common 113 
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interactions between the candidate genes that may be involved in the trans-114 
infection of HIV-1 between DC and T-cells. Analysis of the siRNA candidates was 115 
carried out for cellular compartments and biological processes (Table 1). Our results 116 
show that the genes required for optimal viral transfer are primarily involved in 117 
endocytic compartment regulation, whereas genes that restrict viral transfer are 118 
largely involved in clathrin-coat mediated endocytosis and actin-dependent 119 
processes at the plasma membrane. Taken together the data suggests that 120 
preventing viral uptake via clathrin coated vesicles enhances viral transfer, which is 121 
likely due to increased retention of virus on the cell surface. This finding is in 122 
agreement with studies that show HIV-1 transmitted in trans between DC and T-cells 123 
from the surface of DC (12, 13). In contrast, genes required for efficient trans-124 
infection are strongly associated with cytoplasmic membrane bound vesicles and 125 
vesicle-mediated transport supporting the view that HIV-1 is sequestered into 126 
intracellular virus-containing compartments (VCC) (15, 16, 33).  127 
 128 
ARF1, BIN1, RAB7L1 and RAB8A are required for HIV-1 trans-infection 129 
The siRNA library used to identify target genes is comprised of a set of four 130 
separate siRNA sequences which target different regions of the same gene; these are 131 
pooled to reduce the potential off-target effects of siRNA transfection. The 132 
knockdown of the pooled siRNA typically reflects the most functional siRNA within 133 
the pool. Therefore, the four individual siRNA can be analysed for their ability to 134 
reduce viral transfer to validate whether the observed phenotype is a genuine on-135 
target effect.  136 
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The main aim of our study was to identify cellular pathways involved in the 137 
delivery of HIV-1 to the VS to aid trans-infection; therefore, we focused our 138 
investigation on the genes that facilitate the transfer of HIV-1 between DC and T-139 
cells.  Each of the four siRNA were transfected individually into MDDC, infected with 140 
HIV-1 (R9) and co-cultured with autologous T-cells for 48 hours. Of the final nine 141 
candidates, three showed a reduction in transfer (≥20%) in at least two of the four 142 
individual siRNA, across four independent donors: BIN1 (siRNA B and C), RAB7L1 143 
(siRNA A, C and D) and RAB8A (siRNA A, and B) (Figure 2a). An average reduction of 144 
50% in transfer was evident for ARF1 siRNA A, whereas ARF1 siRNA B produced a 17-145 
20% knockdown in viral transmission in 3 out of the 4 donors analysed. Thus, in 146 
conjunction with the targeted reduction of ARF1 at the protein level, this result 147 
indicates that ARF1 siRNA A was the most functional siRNA in the pool and it was 148 
therefore decided to pursue this candidate further. 149 
To determine the level of protein depletion in MDDC, cell lysates transfected 150 
with 200 nM pooled siRNA (Figure 2b) targeting the entire length of the gene were 151 
analysed by western blot. Knockdown was quantified by densitometry relative to 152 
protein expression levels in non-target siRNA transfected lysates. An efficient 153 
knockdown was achieved using pooled siRNA, 35% (± 17) reduction of protein 154 
expression was observed for ARF1, 52% (± 6.6) for BIN1, 53% (± 23.4) for RAB7L1 and 155 
54% (± 8.1) for RAB8A compared to non-target siRNA (Figure 2c). 156 
To confirm whether siRNA is capable of reducing viral trans-infection 157 
independent of viral strain, MDDC were transfected with the selected target siRNA 158 
and infected with either R8BAL (CCR5-tropic) and R9 (CXCR4-tropic) HIV-1. A 159 
significant reduction in viral transfer - ranging between 26-40% in R9 infected cells 160 
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and 35-45% in R8BAL infected cells - was observed for all candidates demonstrating 161 
that host factors involved in trafficking to the VS are shared for both CXCR4- and 162 
CCR5-tropic strains of HIV-1 (Figure 2d and e). All MDDC transfected with pooled 163 
siRNA remained > 80% viable compared to control cells, ensuring that the reduction 164 
in transfer is not due to cellular toxicity of the siRNA transfection (Figure 2f). Further, 165 
siRNA transfection of MDDC resulted in a marginal (< 5%) increase in DC maturation 166 
marker CD83. Viral binding of p24 Gag also saw a marginal increase compared to 167 
untreated and mock transfected cells, however HIV-1 internalisation was not 168 
affected confirming the observed reduction in trans-infection is not due to 169 
decreased binding or internalisation of the virus (data not shown). 170 
Future experiments were conducted on selected candidate siRNA showing 171 
evidence of protein knockdown and a reduction in viral trans-infection in at least two 172 
of the four individual siRNA tested. siRNA candidate genes that failed to meet these 173 
criteria (WASF1, EPN3, PAK1, and AMPH1) showed no evidence of a reduction in viral 174 
trans-infection when MDDC were transfected with individual siRNA nor were we 175 
able to detect a specific knockdown in protein expression, suggesting the previously 176 
observed reduction in viral trans-infection maybe due to off-target effects of those 177 
specific siRNA. Therefore, these genes were eliminated from further analysis along 178 
with AP1M1 which showed high variability in the reduction of viral transfer between 179 
donors. The final candidates included ARF1, associated with retrograde transport at 180 
the Golgi and protein transport to endosomes (34, 35), BIN-1, known to form a 181 
complex with dynamin to control vesicle transport and scission (36), RAB7L1 a 182 
GTPase required for retromer recycling between the TGN and endosomes (37) and 183 
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GTPase RAB8A involved in polarised vesicular trafficking to the plasma membrane 184 
from TGN (38).  185 
 186 
Depletion of target proteins reduces virological synapse formation between MDDC 187 
and CD4+ T-cells. 188 
The efficient trans-infection of HIV-1 from DC to T-cells is dependent on the 189 
formation of VS, an adhesive structure that promotes viral transmission (39, 40). To 190 
assess if the observed reduction in trans-infection was due to a reduction in VS 191 
formation, siRNA transfected MDDC were infected with HIV-1 R9 or R8BAL and co-192 
cultured with autologous CD4+ T-cells. Imaging of the transfected MDDC revealed 193 
that in the case of BIN1 and RAB7L1 siRNA transfected cells, HIV-1 R9 appeared to 194 
accumulate in large cellular vesicles at the plasma membrane and did not form VS 195 
with the T-cells in spite of apparent interactions between the two cell types. In 196 
addition, ARF1 and RAB8A depleted cells also appear to inhibit VS formation; 197 
however, accumulation of virus can be seen in smaller vesicles at the cell periphery 198 
(Figure 3a). Quantification of VS was similar in non-target siRNA, untreated and mock 199 
transfected cells.  All candidate siRNA had a 40-60% reduction in VS formation 200 
between DC and T-cells when compared to non-target siRNA transfected cells (Figure 201 
3b). Similar results were seen for R8BAL infected MDDC, a reduction in VS number 202 
with T-cells was observed, however BIN1 and RAB7L1 transfected cells did not 203 
accumulate virus in intracellular vesicles to the extent seen in R9 infected MDDC 204 
(Figure 3c, 3d). In addition, we observed that LFA-1, a stabilising component of the 205 
VS, did not become enriched at the interface between the MDDC and T-cells in the 206 
absence of virus (data not shown). These data suggest that virus is targeted to 207 
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cytoplasmic vesicles after entry into MDDC, however onward trafficking of virus to 208 
the plasma membrane is inhibited by depletion of the target genes, preventing VS 209 
formation and reducing efficient trans-infection between the DC and CD4+ T-cells. 210 
 211 
The integrity of virus containing vesicles are compromised in BIN1 and RAB7L1 212 
depleted MDDC cells.  213 
CD81, a type II transmembrane protein, is one of the main tetraspanins 214 
recruited to the host cell membrane during HIV-1 trans-infection and is known to co-215 
localize with HIV-1 containing compartments in macrophages and DC (4, 18, 41). To 216 
determine if target siRNA altered endogenous CD81 localisation in MDDC, 217 
transfected cells were labelled for CD81 (Figure 4a). In control cells (non-target 218 
siRNA) CD81 is found at the cell periphery with a faint perinuclear staining. In 219 
contrast, ARF1 siRNA saw a reduction in CD81 positive vesicles that are evident 220 
within both the cytoplasm and at the cell periphery. BIN-1 and RAB7L1 depletion 221 
reduced CD81 vesicle number and size, whereas no significant difference was 222 
observed in cells depleted of RAB8A (Figure 4b-c). In all three cases, an accumulation 223 
of CD81 vesicles was observed within the cytoplasm not at the cell periphery (Figure 224 
4a).   225 
CD81 plays an important role in regulating viral trans-infection at the VS and 226 
depletion of the tetraspanin can reduce viral trans-infection (42).  In light of previous 227 
findings, we assessed CD81 localisation during HIV-1 infection. As expected, we 228 
observed p24 Gag co-localisation with CD81 at the cell periphery in CD81 229 
tetraspanin-enriched micro domains (TEM) at 4 hours post-infection in control cells. 230 
In transfected MDDC, we observed that the number of CD81 p24 Gag TEM’s are 231 
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reduced in ARF1 depleted cells. In contrast, cells transfected with siRNA targeting 232 
BIN1, RAB7L1 and RAB8A saw both virus and CD81 at the cell periphery, however the 233 
staining of the TEM was diffuse and lacked the structure of the TEM (Figure 4d-e). 234 
This was confirmed by co-localisation data indicating that CD81 association with p24 235 
was reduced in siRNA transfected cells (Figure 4f). Taken together, these data 236 
suggest that trafficking of CD81 and p24 Gag to the cell periphery to form the TEM is 237 
compromised by knockdown of ARF1, BIN-1, RAB7L1 and RAB8A potentially 238 
preventing the efficient trans-infection of virus via the VS. 239 
 240 
Retention of virus in endocytic compartments reduces HIV-1 transfer 241 
We hypothesised that the presence of virus and CD81 in cytoplasmic vesicles 242 
and the disrupted trafficking of CD81 and p24 Gag to the plasma membrane by 243 
target siRNA was due to retention in endocytic compartments. Therefore, we aimed 244 
to trap virus in endosomal derived vesicles to establish if this directly affects viral 245 
trans-infection to T-cells. MDDC were treated with endocytic inhibitors prior to 246 
infection with R9 virus and the level of trans-infection was measured. We utilised 247 
LY294002, a phosphatidylinositol 3-kinase (PI3K) inhibitor known to block 248 
macropinocytosis and the formation of early endosomes, and Bafilomycin A1, a 249 
vacuolar type H+-ATPase (V-ATPase) that prevents endosomal acidification.   250 
Inhibition with LY294002 resulted in a mild increase of HIV-1 trans-infection 251 
(+ 20%) when compared to DMSO treated control cells. However, a 2-fold decrease 252 
in trans-infection was observed in cells treated with Bafilomycin A1, indicating that 253 
efficient viral transfer requires a functioning endocytic pathway (Figure 5a). This 254 
reduction was not due to inhibitor toxicity, with MDDC remaining > 80% viable 255 
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during treatment and subsequent infection (Figure 5b). To visualise any differences 256 
between MDDC treated with LY294002 and Bafilomycin, infected MDDC were 257 
analysed by confocal microscopy. HIV-1 was concentrated at the cell surface in cells 258 
pre-treated with LY294002, which is in agreement with previous findings (13). In 259 
contrast, virus accumulates inside intracellular vesicles in cells treated with 260 
Bafilomycin A1 (Figure 5c) indicating that viral uptake into MDDC was not inhibited, 261 
and retention within endocytic vesicles reduced trans-infection. Controls confirmed 262 
that both horseradish peroxidase (HRP) taken into the MDDC via fluid–phase and the 263 
lysosomal marker low-density lipoprotein (LDL) were lost in cells treated with the 264 
PI3K inhibitor LY294002, as predicted. In contrast, LDL-Dil labelling was diffuse and 265 
cytoplasmic in cells treated with Bafilomycin A1, suggesting a block in LDL-Dil uptake 266 
by endosomes in the MDDC. On the contrary, HRP taken up via fluid-phase was less 267 
affected, suggesting that unlike LDL, HRP is retained in endocytic-like compartments 268 
(Figure 5d). 269 
HIV-1 did not co-localise with organelle markers EEA1, Rab5, Rab7, Rab11, 270 
LAMP2 or CHMP2B in either siRNA transfected or Bafilomycin A1 treated MDDC in 271 
our experiments, suggesting that these HIV-1 positive compartments may be 272 
intermediate vesicles devoid of characteristic markers.  273 
Taken together, these data indicate that HIV-1 transfer is reliant on a 274 
functioning endocytic pathway. Blocking virus in endosomal derived compartments 275 
results in the accumulation of virus in cytoplasmic vesicles, which in turn reduces 276 
viral transfer between MDDC and T-cells, as seen in siRNA transfected MDDC. In 277 
addition, Bafilomycin A1 appears to block LDL-DIL but not HRP or HIV-1 uptake into 278 
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MDDC, suggesting that HIV-1 is predominately trafficked to cellular compartments 279 
that differ from those utilised by LDL. 280 
 281 
Downstream trafficking from early endosomes is compromised in MDDC 282 
transfected with target siRNA 283 
Endosomal cargo has one of two fates; it is either recycled back to the cell 284 
surface (i.e. transferrin) or directed to lysosomes for degradation (i.e. LDL). To 285 
confirm that target siRNA are blocking endosomal trafficking in MDDC, cells were 286 
transfected with pooled ARF1, BIN-1, RAB7L1 and RAB8A siRNA and either stained 287 
for early endosomes with early endosome antigen 1 (EEA1), incubated with Alexa 288 
Fluor labelled Transferrin, or LDL-DIL, to assess the recycling and lysosomal 289 
trafficking pathways respectively. 290 
In non-target siRNA transfected MDDC, EEA1 is seen in numerous vesicles of 291 
various sizes throughout the cell.  MDDC transfected with siRNA against ARF1, BIN1 292 
and RAB8A resulted in the formation of abnormal endosomes marked by a decrease 293 
in both number and size.  RAB8A siRNA resulted in more numerous, enlarged 294 
vesicles evident at the cell periphery (Figure 6a-c).   295 
In all instances labelled transferrin was found localised at the cell periphery, 296 
with no discernible differences between control and siRNA transfected cells (Figure 297 
6a, panel 2). However, a reduction in vesicle number and Alexa Fluor labelling was 298 
observed in BIN1, RAB7L1 and RAB8A transfected cells (Figure 6d-e).  299 
In non-target siRNA or mock transfected control cells, LDL-DIL predominately 300 
accumulates in lysosomes in the perinuclear region. In cells transfected with siRNA 301 
targeting ARF1, LDL has accumulated in various sized vesicles in the cytoplasm 302 
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(Figure 6a, panel 3). Knockdown of BIN-1, RAB7L1 resulted in a reduction of LDL 303 
containing vesicles within the cells indicating that the delivery of LDL-DIL to 304 
lysosomes is significantly reduced (Figure 6a, f-g).  RAB8A-silenced cells were also 305 
found to have a reduced number of LDL vesicles; however, a diffuse staining is 306 
evident within the cytoplasm, suggesting that LDL is taken into the cell but not 307 
trafficked within the endolysosomal pathway.  308 
These observations suggest ARF1 regulates endosomal morphology and 309 
vesicle formation and slows LDL trafficking to the perinuclear region but is 310 
dispensable for the recycling of transferrin to the plasma membrane.  BIN1 and 311 
RAB7L1 also affect endosomal vesicle formation, resulting in the retention of vesicles 312 
at the cell periphery and reducing downstream trafficking from endosomes, 313 
evidenced by a reduction in both transferrin and LDL containing vesicles suggesting 314 
BIN1 and RAB7L1 play a role in early endosomal protein trafficking. In contrast, 315 
RAB8A depletion appears to increase early endosome size, although trafficking of 316 
both LDL and transferrin is also reduced suggesting RAB8A actions is targeted more 317 
downstream regulating protein trafficking after cargo has left the endocytic 318 
compartment. The disruption of endosomal vesicle trafficking at or after the early 319 
endosomal compartment by target siRNA creates a knock-on effect, altering 320 
endocytic trafficking to lysosomes and recycling of cargo to the plasma membrane. 321 
Taken together, the disruption of TGN-endosomal-plasma membrane trafficking 322 
suggests that HIV-1 trafficking from internalised compartments relies of endosomal 323 
sorting pathways to traffic to and accumulate at the VS and potentially within VCC at 324 
the cell surface. 325 
 326 
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HIV-1 trans-infection requires retromer complex recycling of cargo 327 
Based on the findings that trafficking between key endosomal compartments 328 
is compromised in siRNA targeted cells which in turn reduces HIV-1 trafficking to the 329 
VS - we wanted to confirm whether trans-infection of HIV-1 was reduced when 330 
trafficking to the plasma membrane from the TGN or early endosomes is 331 
compromised. Several of our selected genes play a key role in endosomal sorting to 332 
the TGN and plasma membrane with RAB7L1 specifically involved in retromer 333 
activity. In addition, a proportion of transferrin and its receptor are recycled in a 334 
retromer-dependant manner to the plasma membrane (43). The retromer has also 335 
been found to play a key role in HIV-1 Env trafficking and viral assembly (44). Thus, 336 
we decided to investigate the role of the retromer complex in trans-infection using 337 
siRNA targeting key components of the retromer complex, VPS26A and VPS35. HIV-1 338 
trans-infection was significantly reduced in MDDC transfected with each of the 339 
retromer siRNA (Figure 7a-b) from 25-50%.  A more marked reduction was evident in 340 
cells infected with CXCR4-tropic strain of the virus.  A protein knockdown of 341 
approximately 60% was confirmed for both VPS26A and VPS35 (Figure 7c-e), and no 342 
reduction in cell viability was evident from siRNA transfection of the VPS genes.  343 
Therefore, we were able to confirm endosomal sorting between the TGN and to the 344 
plasma membrane is required for HIV-1 trans-infection.  345 
 346 
DISCUSSION 347 
DC perform an essential role in the transmission of HIV-1 to target CD4+ T-348 
cells promoting the spread of infection. Although there have been numerous 349 
investigations into the role of DCs in trans-infection, the cellular trafficking pathways 350 
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exploited by HIV-1 remain unclear. The identification of host cell factors and 351 
intracellular pathways exploited by HIV-1 to aid trans-infection of T-cells will 352 
facilitate the development of novel therapies and may reduce initial transmission of 353 
HIV-1. 354 
 355 
In this study we identified a number of host factors involved in trans-356 
infection of HIV-1 from DC to T-cells. By conducting a siRNA screen targeting 357 
membrane trafficking proteins we identified four genes involved in efficient trans-358 
infection from DC to T-cells. Although, one similar shRNA/siRNA screen has been 359 
conducted investigating the role of membrane trafficking in HIV-1 trans-infection, 360 
none to date has focused on the genes we identified in the current study. In a recent 361 
shRNA screen Menager and Littman (13) also identified ARF1, ARF6 and ARPC1B as 362 
reducing viral transfer and CLTC, CLTB and AP2M1 enhanced viral transfer, however 363 
the ability to draw direct comparisons between the two studies is complicated by the 364 
fact that Menager uses shRNA technology in a screen that targets a different gene 365 
library, several of them not included in the siRNA screen we utilised. The study then 366 
proceeds to concentrate on TSPAN7 and DNM2 and their role in trans-infection at 367 
the cell surface, whereas we have focused on the trafficking of internalised virus. In a 368 
study using an identical siRNA screen, Wen et al. identify a number of common 369 
genes such as RAB7L1, AP1M1, BIN-1, ARPC1B, DIAPH1, ARF6, WASF1, CLTC and 370 
VAV2 required for HIV-1 and M-PMV virus release from HeLa cells (45). Overall, there 371 
is a high consistency of hits between previous screens conducted in DCs and our own 372 
membrane trafficking screen, verifying our findings.  373 
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Our initial siRNA screen shows that knocking down genes associated with 374 
clathrin-coated vesicle formation enhanced trans-infection; this suggests that 375 
restricting viral uptake into MDDC and retention of virus on the cell surface 376 
promotes HIV-1 trans-infection. It has been previously demonstrated that soluble 377 
CD4 protein is able to inhibit infection therefore proposing that virus particles bound 378 
to the surface of the MDDC were the main source of trans-infection (12). In support 379 
of this model, Menager et al. demonstrated that DNM2 and TSPAN7, which 380 
coordinate actin nucleation and stabilization, had roles in restricting endocytosis and 381 
maintaining virus on cellular dendrites enabling transfer (13, 46). On the other hand, 382 
there is compelling evidence for the model that HIV-1 is sequestered in plasma 383 
membrane-derived invaginated compartments induced upon HIV-1 uptake (33). 384 
From this compartment, viral particles can be released to the VS to initiate trans-385 
infection (15-17). We initially identified 9 genes from the siRNA screen that reduced 386 
trans-infection. These genes were predominately associated with cytoplasmic, 387 
membrane-bound vesicles with direct involvement in vesicle-mediated transport and 388 
membrane organisation, thus supporting a requirement for membrane-bound 389 
vesicles in HIV-1 trans-infection.  These results provide evidence for both viral 390 
transmission via the cell surface and trafficking via intra-cellular compartments to 391 
promote trans-infection in MDDC.  392 
Although the use of primary MDDC and CD4+ T-cells is a representative 393 
model of HIV-1 trans-infection, employing methods such as siRNA transfection 394 
within established MDDC has its limitations. Generally, 50% transfection efficiency is 395 
achieved, which in turn does not completely block reduction of trans-infection within 396 
these cells. However, partial knockdown is still capable of producing a strong 397 
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phenotype and the study of these pathways in primary cells is essential to 398 
uncovering underlying mechanisms of trans-infection and is critical for investigating 399 
and identifying such cellular processes.  400 
In this study, we concentrate on studying genes required for efficient viral 401 
trans-infection and therefore aim to investigate how internalised virus is trafficked 402 
to the VS.  We demonstrate that the reduction in viral trans-infection observed from 403 
depletion of four genes: ARF1, BIN1, RAB7L1 and RAB8A is due to the apparent 404 
retention of virus in intra-cellular vesicles and a reduction in virus accumulation at 405 
the VS between DC and T cells.  MDDC are able to capture and store HIV-1 virions in 406 
invaginations at the plasma membrane (9, 15).  Live-imaging shows viral puncta are 407 
trafficked into enclosed intracellular compartments (47), whether these 408 
compartments are enclosed or remain accessible to the cell surface is still at matter 409 
of debate (15, 16). The integrity and formation of intracellular compartments are 410 
believed to be regulated by membrane trafficking processes (17). Based on this data 411 
we propose that the reduction in VS formation observed in siRNA-treated MDDC 412 
disrupts the regulation and trafficking of intra-cellular compartments resulting in the 413 
retention of viral particles within intra-cellular vesicles, preventing onward 414 
trafficking to the VS and therefore inhibiting viral trans-infection. 415 
VS formation and HIV-1 spread relies on the interaction of MDDC and 416 
recipient T-cells, triggering the active polarisation of organelles and cell surface 417 
proteins.  One such component, LFA-1, has been shown to induce T-cell polarisation 418 
towards the VS to induce efficient viral T-cell-to-T-cell spread (48). In the context of 419 
VS formation between DC and T-cells it has been reported that cell-to-cell contacts 420 
are not increased by the presence of HIV-1 and the formation of the VS was 421 
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decreased by 60% when the interaction between ICAM-1 and LFA-1 was blocked 422 
(49).  Our findings agree with this data, we also observe several T-cells interacting 423 
with HIV-1-infected siRNA-transfected MDDC; however accumulation of LFA-1 at the 424 
VS was only evident in the presence of HIV-1 p24 Gag. These data suggest that by 425 
blocking trafficking of HIV-1 to the cell periphery, enrichment of LFA-1 at the MDDC-426 
T-cell interface is also prevented, restricting VS formation. It may be the case that 427 
virus alone is not the only trigger for VS formation and it is plausible that by blocking 428 
trafficking of HIV-1 to the cell surface in MDDC we may also be preventing the 429 
recruitment of other key components to form efficient VS. 430 
We also observe the retention of endogenous CD81 in cytoplasmic vesicles 431 
and a reduction of localisation at the cell periphery. In addition, at 4 hours post-432 
infection, TEMs are reduced or disrupted and potentially affecting the recruitment 433 
and budding of HIV-1 at the VS. The tetraspanin CD81 co-localises with HIV-1 within 434 
VCC (4, 18, 41) and accumulates at the VS promoting viral trans-infection, preventing 435 
cell-to-cell fusion and providing a platform for viral budding (50, 51). Our results are 436 
consistent with these findings suggesting that trafficking of CD81 within MDDC to 437 
the plasma membrane and recruitment to TEMs, along with HIV-1, are required for 438 
trans-infection. This is supported further by a study showing that blocking CD81 with 439 
specific antibodies reduces VS formation (52). Although conversely, Krementsov and 440 
colleagues show that direct depletion of CD81 actually enhances viral transmission 441 
between HeLa and Jurkat cells (53). The different outcomes observed in these 442 
studies may reflect the different methods and cell types employed to target CD81 443 
and reduce its presence at the VS. Our data supports the former approach where 444 
CD81 is still present within the cell, but is prevented from forming functioning TEMs 445 
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at the cell periphery, whereas actual depletion of CD81 from cells may have a 446 
number of downstream effects, altering normal cell function.  447 
Overall, we demonstrate that targeting host factors that regulate endocytic 448 
compartments and vesicle trafficking to the plasma membrane within MDDC results 449 
in the disruption of trafficking of CD81 and virus to the VS reducing trans-infection. 450 
Our results show that upon disruption of target genes, protein trafficking to 451 
lysosomes and recycling of transferrin to the plasma membrane is reduced: this 452 
suggests that endosomal sorting and recycling to the plasma membrane are closely 453 
linked to trans-infection in MDDC. 454 
In conjunction with other ARF proteins, ARF1 plays an important role in the 455 
regulation of recycling endosome morphology and recycling pathways, however 456 
depletion of the gene was not found to directly affect the recycling of transferrin 457 
receptor (54, 55).  Depletion of ARF1 in our study is consistent with this role in 458 
protein recycling in MDDC, altering endosomal morphology but not affecting 459 
recycling of transferrin to the plasma membrane.  In the context of infection, HIV-1 460 
ability to mediate the down-regulation of MHC-1 is achieved by targeting AP-1 and 461 
ARF1 activity (56) resulting in the accumulation of MHC-1 in the TGN or endosomes 462 
(57). HIV-1 Vpu also targets the same pathway (58, 59) to counteract tetherin, 463 
known to block the release of progeny virus from the cell (60).  This data in 464 
conjunction with the fact that ARF1 binding partner AP1M1 was originally identified 465 
as a potential gene required for trans-infection in our screen, supports the idea that 466 
the same recycling pathway could be utilised for the successful trans-infection of 467 
HIV-1 in DC. Depletion of ARF1 is likely to impact on the morphology of virus 468 
containing compartments and recycling of internalised virus to the cell surface, 469 
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which in turn reduces the accumulation of virus at the VS and therefore trans-470 
infection. 471 
BIN-1 is a key player in membrane remodelling during endocytosis and 472 
endosomal sorting, essential for the formation of plasma invaginations in muscle 473 
tissue (61). BIN-1 mutants were found to both impair membrane tabulation and 474 
cause compact membrane curvature (62). Our findings support these data: depletion 475 
of BIN-1 in MDDC reduces endosomal size, producing small round vesicles 476 
preventing downstream trafficking. A role for BIN-1 in HIV-1 infection is supported 477 
further by a study that identifies the up-regulation of BIN-1 in CD4+ and CD8+ T-cells 478 
from ex vivo patients (63).  Based on this, we propose that BIN-1 is required for the 479 
efficient formation and function of plasma membrane invaginations and endosomal 480 
sorting that assist the trafficking of HIV-1 to the VS.  481 
RAB7L1 is also found to have a role in intracellular trafficking and the 482 
endosomal sorting of lysosomal bound membrane proteins (64). Again, our results 483 
support a similar role for RAB7L1 in MDDC, the transport of both LDL and transferrin 484 
was impaired in RAB7L1 depleted MDDC, suggesting that trafficking from endosomal 485 
compartments is compromised. The finding that RAB7L1 along with AP1M1 are 486 
involved in HIV-1 Gag trafficking and virion budding in the activated macrophage cell 487 
line MM6 and CD4+ Jurkat cells (65), supports a role for RAB7L1 in the recruitment 488 
of HIV-1 particles in MDDC to the VS to assist viral budding at the cell surface. 489 
RAB8A is known to control vesicular transport and promote membrane 490 
protrusions, which can be inhibited by blocking membrane recycling (66) agreeing 491 
with our findings.  Knockdown of RAB8A by siRNA in previous studies was found to 492 
inhibit HIV-1 replication in Hela P4/R5 cells and directly interact with nef, env and 493 
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gag-pol (67).  Therefore, it seems plausible that the depletion of RAB8A in MDDC 494 
inhibits membrane recycling and therefore membrane protrusions, reducing HIV-1 495 
trans-infection. The data also supports the idea that HIV-1 taken up by MDDC could 496 
rely on the same recycling pathways to traffic to the cell membrane to accumulate 497 
virus at the VS. 498 
The data presented in this study clearly points to a role for endocytic 499 
recycling pathways in HIV-1 trans-infection; therefore we investigated the retromer 500 
complex implication in the trafficking of HIV-1 to the VS.  Retromer-dependent 501 
protein sorting pathways provide an opportune target for a variety of viral and 502 
bacterial pathogens (68, 69). For instance, HIV-1 envelope protein and herpesvirus 503 
saimiri, a T-lymphotrophic tumour virus, bind the retromer to aid infection and viral 504 
release (44, 70), whereas influenza A M2 protein escapes degradation via 505 
transportation from early endosomes to the TGN (71). Our data confirms a role for 506 
the retromer in DC-mediated HIV-1 trans-infection and exploitation of recycling 507 
pathways by the virus to achieve efficient transfer between cells. 508 
We hypothesise that VCC and VS formation is dependent on the retromer-509 
dependent endocytic-TGN-plasma recycling pathway. By exploiting the retromer 510 
pathway, internalised viral particles can be subverted to the plasma membrane 511 
where virus becomes sequestered to promote VS formation and enable trans-512 
infection between MDDC and T-cells (Figure 8). 513 
DC are among the most important cellular targets in early HIV-1 transmission. 514 
HIV-1 is thought to accumulate in ‘viral endosomes’ where the virus is able to exploit 515 
a pathway essential for the delivery of components to the immunological synapse 516 
and activation of T-cells (4). Uptake into DC using this method not only allows 517 
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efficient trans-infection to target CD4+ T-cells but also evades detection by the 518 
immune system (27), the importance of which was shown in vivo using a humanised 519 
mouse model (10, 11). 520 
By using high-throughput siRNA screening we were able to identify ARF1, 521 
BIN1, RAB7L1 and RAB8A that are essential for endosomal trafficking between the 522 
TGN and early endosomes and co-ordinated transport to the plasma membrane in a 523 
retromer-dependent manner. Thus, we identify key cellular trafficking proteins 524 
exploited by HIV-1 in DC to efficiently disseminate virus to target T-cells promoting 525 
trans-infection. A better understanding of the role of these proteins in viral transfer 526 
to T-cells may serve as potential candidates for targeted therapy to control the 527 
transfer of HIV-1 between DC and T-cells in vivo. 528 
 529 
EXPERIMENTAL PROCEDURES 530 
Ethics statement 531 
Peripheral blood mononuclear cells (PMBC) were derived from buffy coats obtained 532 
from healthy blood donors, anonymously provided by the Welsh Blood Service, UK. 533 
Written informed consent for the use of buffy coats for research purposes was 534 
obtained from blood donors and the use of patient samples and procedures were 535 
approved by the local research ethics committee at Cardiff University.  536 
 537 
Cells  538 
Primary cells were isolated from PMBC of healthy blood donors using magnetic bead 539 
selection (Miltenyi Biotech).  CD14+ monocytes were differentiated into immature 540 
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monocyte-derived dendritic cells (MDDC) with IL-4 and GM-CSF, as described 541 
previously (72, 73). 542 
CD4+ T-cells were isolated using CD4+ magnetic beads (Miltenyi Biotech) and 543 
maintained in the presence of IL-2 and activated 4 days before use with 2 µg/mL 544 
phytohemagglutinin (PHA). SUP-T1 T-lymphoblasts and 293T human embryonic 545 
kidney (HEK) cells (obtained from NIH AIDS Research & Reference Reagent Program) 546 
were maintained in supplemented RPMI 1640 or DMEM respectively. 547 
 548 
Viral stock production 549 
Viral stocks were produced by transfection of HEK293T cells with calcium phosphate 550 
DNA precipitation of proviral plasmids encoding full length HIV-1 X4 and R5 provirus, 551 
pR9 and pR8BAL respectively (plasmids provided by Trono D, EPFL, Lausanne). 552 
Infectious titres were determined by titration onto SUP-T1 cells and quantification of 553 
HIV-1 p24 Gag by ELISA using the Lenti-X p24 rapid titre kit (Clontech).  554 
 555 
Antibodies and reagents 556 
HIV-1 p24 was detected using anti-HIV-1 core antigen antibody-FITC (KC57-FITC – 557 
Beckman Coulter), and actin labelled with Cytopainter Phallodin-iFluor-555 (abcam). 558 
Protein knockdown was detected by immunoblotting using rabbit anti-ARF1, anti-559 
BIN1, anti-RAB8A, mouse anti-Rab7L1 (abcam), and Actin (Merck) followed by 560 
secondary HRP conjugated goat anti-rabbit and anti-mouse (DAKO). Confocal 561 
microscopy was carried out using primary antibodies, anti-human CD81-APC (BD), 562 
anti-EEA1, anti-CHMP2B, anti-LAMP1, anti-Rab7, anti-Rab11, anti-Rab5 (abcam). 563 
Horse radish peroxidase (HRP) uptake was detected using anti-HRP (Jackson 564 
 on M
arch 12, 2020 at CARDIFF UNIVERSITY
http://jvi.asm
.org/
Downloaded from
 
HIV trans-infection requires endosomal sorting 
 
 2
5 
Immunolaboratory). All unlabelled primary antibodies were detected with secondary 565 
anti-rabbit Alexa Fluor 546 (Life technologies). Pharmacological inhibitors: LY294002, 566 
Bafilomycin A1, Indinivir (Sigma Aldrich) were used at 50 µM, 0.5 µM and 2 µg/mL 567 
respectively. 568 
 569 
 570 
 571 
RNAi screen in MDDC 572 
siRNA screen was performed using a commercially available SMARTpool ON-TARGET 573 
library containing 140 membrane trafficking genes (Dharmacon-GE Healthcare, also 574 
see table S1). MDDC (1 x105 cells/well) seeded in 96 well plates were reverse 575 
transfected twice, 24 hours apart, with 200 nM of pooled siRNA or with control 576 
siRNA (SMARTpool ON-TARGET Non-target siRNA, Dharmacon-GE Healthcare) using 577 
HiPerFect transfection reagent (Qiagen) in serum free media. After 48 hours, MDDC 578 
were infected with 20-30 ng p24 Gag HIV-1 R9 by spinoculation and co-cultured with 579 
SUP-T1 or CD4+ T-cells pre-stained with CelltraceTM Far Red (Invitrogen) in the 580 
presence of Indinivir 2 µg/mL (Sigma) for a further 48 hours, as previously described 581 
(72).  582 
 583 
Flow Cytometry 584 
Phenotyping of primary cells was performed by washing MDDC and CD4+ T-cells in 585 
ice cold buffer (PBS, 0.5% BSA) before staining for HLR-DR, CD209, CD83 or CD14-586 
APC (BD). SUP-T1 and autologous T-cells were labelled with CD4 and CD3-APC (BD). 587 
Cell viability was assessed using LIVE/DEAD stain 1:1000 (Life Technologies) in PBS, 588 
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as per manufacturer’s instructions. Infected MDDC and CD4+ T-cells were fixed in 2% 589 
PFA and stained for HIV-1 p24 Gag-FITC after permeabilisation with 1x PhosFlow 590 
buffer (BD). Stained samples were washed twice before measurements were taken 591 
on the FACS Calibur (Beckton Dickinson) Canto II and analysed using Flowjo V10 592 
software (Flowjo, LLC). 593 
 594 
 595 
Transfer Assay 596 
MDDC (1 x105 cells/well) were reverse transfected twice, 24 hours apart, with 200 597 
nM of pooled or individual siRNA using HiPerFect transfection reagent (Qiagen) in 598 
serum free media.  After 48 hours, MDDC were infected with 5-10 ng p24 Gag HIV-1 599 
R9 or 2-5 ng p24 Gag HIV-1 R8BAL by spinoculation for 2 hours and co-cultured with 600 
CD4+ T-cells pre-stained with CelltraceTM Far red (Invitrogen) at 37°C for a further 48 601 
hours. 602 
 603 
Western Blot Analysis 604 
At 72 hours post-transfection cells were lysed with 1x cell lysis buffer (Cell Signalling) 605 
and supernatants harvested and reduced.  Cell lysates were separated on a 4-12% 606 
SDS-PAGE gel and run next to a PAGEruler (Thermofisher) before being subjected to 607 
western blotting followed by ECL detection and densitometry analysis (MyImage 608 
Analysis, ThermoScientific). 609 
 610 
Uptake Assays 611 
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Transfected MDDC were incubated with HRP (Sigma) 10 mg/mL for 1 hour at 4°C 612 
prior to fixation on coverslips using 2% Paraformaldehyde (PFA) and labelled using 613 
indicated antibodies.  614 
Transfected MDDC (1x105) were seeded onto poly-L-lysine coverslips and placed at 615 
4°C for 10 minutes prior to the addition of either 12 µg/mL LDL-DIL (Life 616 
Technologies) for 4 hours or 25 µg/mL Tranferrin Alexa Fluor 488 (Life Technologies) 617 
for 30 minutes, both at 37°C. Cells were fixed in 1% PFA and nuclei labelled with 618 
TOPRO-3 (Life Technologies). 619 
 620 
Inhibition assays 621 
Inhibitors LY294002 (50 µM) and Bafilomycin A1 (0.5 µM) were added to MDDC 1 622 
hour prior to and during infection with R9 HIV-1. DMSO was used as a control at 623 
equal concentrations.  Cells were either seeded on coverslips and fixed in 2% PFA for 624 
confocal imaging, or washed and co-cultured with CD4+ T-cells for 48 hours at 37°C 625 
for analysis via flow cytometry. 626 
 627 
Virological synapse assay 628 
MDDC transfected with siRNA were infected with HIV-1 for 2 hours prior to 629 
incubation with CD4+ T-cells on Poly-L-Lysine coverslips at 1:1 ratio for 40 minutes at 630 
37°C. Fixed cells (2% PFA) were labelled for Actin and p24 Gag-FITC and viewed on 631 
the confocal microscope. Virological synapse formation was counted if an 632 
accumulation (approx. 50% or greater) of p24 Gag was evident at or adjacent to the 633 
junction between T-cells and MDDC. T-cells were identified by their smaller size and 634 
less cytoplasmic content in comparison to larger MDDC. 635 
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 636 
Confocal Immunofluorescence 637 
Cells were adhered to Poly-L-Lysine coverslips (Corning), fixed in 2% PFA, 638 
permeabilised with 0.05% saponin and stained with indicated primary antibodies in 639 
PBS/0.2% BSA/0.05% saponin followed by Alexa Fluor labelled secondary antibodies 640 
(1:400) when necessary. TOPRO3 in PBS (1:1000) was used to stain nuclei (Life 641 
Technologies).  Confocal microscopy analysis was carried out using Zeiss LSM710 642 
using 100x oil objective with 488, 546, 633nm acquired sequentially using ZENlite 643 
software (Zeiss). All confocal images represent a single plane. Co-localisation analysis 644 
was performed using Zenlite software (Zen Blue) using the co-localisation function. 645 
 646 
Bioinformatics - Protein Interrelationship mapping 647 
RNAi screen candidates were enriched using DAVID to identify significant gene 648 
ontology (GO) terms and a protein-protein interaction network was visualised using 649 
EnrichmentMap (Bader Lab) plug-in for Cytoscape 3.3.3; the top 5 significant values 650 
were reported. The minimum confidence score was set at 0.005 (74-77). 651 
 652 
Image Analysis 653 
Image analysis was performed using ImageJ software (NIH) and analysed with Excel 654 
software (Microsoft). A macro was designed to apply a set scale to all images 655 
followed by the colour threshold to eliminate any background staining and the 656 
particle analysis function was applied to quantify vesicles. Pixels were converted to 657 
µM using the set scale. 658 
 659 
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Statistics 660 
Data was analysed using a two-sample T-Test, comparing non-target to targeted 661 
siRNA samples. A one sample T-test was used to compare siRNA transfer assays 662 
across donors. P-values <0.05, <0.005, <0.0005 were considered significant marked 663 
*, **and *** respectively. Data was analysed using Prism (Graphpad) software. 664 
 665 
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 950 
FIGURE LEGENDS 951 
Figure 1. The procedure and results of the siRNA screen used to investigate trans-infection 952 
of HIV-1 between MDDC and T-cells. 953 
A) Schematic of the method used to study the effects of siRNA knockdown on HIV-1 954 
trans-infection between DC and CD4+ T cells. 955 
B) Results of siRNA screen on HIV-1 trans-infection between MDDC and CD4+ T-956 
cells. Red dashed lines indicate the assay cut off of -20% and +50% for non-957 
specific variation of the assay. siRNA that reduced or increased HIV-1 trans-958 
infection above or below the cut-off point (HITS) are listed in the grey boxes. 959 
C) Identification of genes that reduced HIV-1 trans-infection between MDDC and T-960 
cells. Results from initial screen conducted in SUPT1 cells (○) are shown in 961 
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combination with repeats conducted in with autologous CD4+ T-cells (●). Mean 962 
and SD of three independent donors shown. Only genes with a mean percentage 963 
below that of the non-target siRNA are shown. 964 
D) Identification of genes that increase HIV-1 trans-infection between MDDC and T-965 
cells. Results from initial screen conducted in SUPT1 (○) cells are shown in 966 
combination with two repeats conducted in with autologous CD4+ T-cells (●). 967 
The mean and SD of three independent donors was calculated per gene. Only 968 
genes with a mean above that of the non-target siRNA are shown. 969 
 970 
Figure 2. ARF1, BIN1, Rab7L1 and RAB8A regulate DC T-cell HIV trans-infection 971 
A) Validation of siRNA knockdown on trans-infection against four individual siRNA 972 
from each candidate gene. Percentage of HIV-1 transfer is normalised to non-973 
target siRNA set at a value of 1.0. Each point represents an individual donor. 974 
The mean and SD ± is shown. * p< 0.05, ** p< 0.005. 975 
B) Western blot analysis of pooled siRNA knockdown in MDDC at 72 hours post-976 
transfection with ARF1, BIN1, RAB7L1 and RAB8A siRNA performed in triplicate, 977 
untreated MDDC and non-target siRNA. Actin is used as a loading control.  978 
C) Densitometry quantification of protein expression levels for ARF1, BIN1, RAB7L1 979 
and RAB8A. Protein expression levels for siRNA transfected MDDC normalised 980 
to actin loading control. All values are relative to non-target siRNA transfected 981 
lanes (Set at 1.0). Mean and SD ± shown, n=3. 982 
D) The effects of final target siRNA on HIV-1 trans-infection infected with CXCR4 983 
(R9).  The reduction in viral transfer is measured relative to Non-target siRNA. 984 
Mean and SD shown for each sample (n = 5) * p < 0.05, ** p < 0.005. 985 
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E) The effects of final target siRNA on HIV-1 trans-infection infected with CCR5 986 
(R8Bal).  The reduction in viral transfer is measured relative to Non-target 987 
siRNA. Mean and SD shown for each sample (n = 5) * p < 0.05, ** p < 0.005. 988 
F) The effects of ARF1, BIN1, RAB7L1, RAB8A siRNA transfection on the viability of 989 
MDDC at 48 hours post-transfection. All samples compared to untreated MDDC. 990 
Cell viability is shown as a percentage. Mean ± SD, n = 2. 991 
 992 
Figure 3. ARF1, BIN1, RAB7L1 and RAB8A are regulators virological synapse formation 993 
between HIV-1 infected MDDC and CD4+T-cells. 994 
A) Images of CXCR4 HIV-1 R9 (p24 green) infected, siRNA transfected MDDC 995 
interacting with CD4+ T-cells (identified with *).  Actin = red, nuclei = blue. 996 
Scale= 10 µM. 997 
B) Quantification of virological synapse formation between MDDC and CD4+ T-998 
cells was counted in siRNA transfected MDDC infected with HIV-1 R9 and co-999 
cultured with autologous CD4+ T-cells. T-cells were identified as the smaller 1000 
cells with less cytoplasmic content compared to the larger MDDC in co-culture. 1001 
Data normalised to MDDC transfected with non-target siRNA. The mean and SD 1002 
of three independent donors (n = 500 cells) is shown. ** p < 0.05. ** p < 0.05. 1003 
C) Images of CCR5 HIV-1 R8BAL (p24 green) infected, siRNA transfected MDDC 1004 
interacting with CD4+ T-cells (identified with *).  Actin = red, nuclei = blue. 1005 
Scale= 10 µM. 1006 
D) Quantification of virological synapse formation between MDDC and CD4+ T-1007 
cells was counted in transfected MDDC infected with HIV-1 R8BAL and co-1008 
cultured with autologous CD4+ T-cells. Data normalised to MDDC transfected 1009 
with non-target siRNA. The mean and SD of three independent donors (n = 300 1010 
cells) is shown.  ** p < 0.05. ** p < 0.05. 1011 
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 1012 
Figure 4. CD81 localisation and TEM formation is disrupted in MDDC transfected with 1013 
ARF1, BIN1, RAB7L1 and RAB8A siRNA. 1014 
A) The effects of target siRNA on CD81 staining and localisation in MDDC.  CD81= 1015 
green, nuclei = blue. Scale = 10 µM. 1016 
B) Quantification of CD81 vesicles in target siRNA transfected MDDC compared to 1017 
non-target siRNA control (n = 110 cells, across three independent donors). 1018 
Mean and SEM shown* p < 0.05, *** p < 0.0005. 1019 
C) Average size (µM) of CD81 positive vesicles in MDDC transfected with target 1020 
siRNA compared to non-target siRNA (n = 150 cells, across three independent 1021 
donors). Mean and SEM shown. ** p < 0.005, *** p < 0.0005. 1022 
D) Images of CD81 (red) and HIV-1 p24 Gag (green) in infected MDDC transfected 1023 
with non-target and target siRNA. Images show HIV-1 4 hours post-infection. 1024 
Nuclei = Red (spherical). Scale 10 µM. 1025 
E) Quantification of CD81 and p24 at tetraspanin enriched domains (TEM) in 1026 
infected MDDC at 4 hours post-infection. The mean percentage of cells with 1027 
HIV-1 p24 Gag localised at CD81 enriched TEMs is represented by black bars. 1028 
White bars represent the absence of CD81 enriched TEMs. Mean percentage 1029 
and SD is shown. N = 170 cells, across 2 independent donors. 1030 
F)  Co-localisation analysis of TEM in siRNA transfected MDDC compared to control 1031 
cells. The co-localisation coefficient of CD81 with HIV-1 p24 Gag is shown for 1032 
each condition. Mean and SEM± shown, n=11 fields analysed over 2 1033 
independent donors. **p < 0.005, *** p < 0.0005 1034 
 1035 
Figure 5. Retention of virus in endocytic derived compartments reduces HIV trans-infection 1036 
from DC to T-cells. 1037 
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A) The effect of LY294002 and Bafilomycin A1 treatment on HIV-1 transfer. MDDC 1038 
were pre-treated with inhibitors overnight prior to infection with HIV-1 (R9) 1039 
before co-culture with autologous CD4+ T-cells for 48 hours in triplicate in 2 1040 
independent donors. Mean percentage (%) viral transfer and SD shown, ***p < 1041 
0.0005. 1042 
B) Percentage viability of MDDC after overnight incubation with LY294002 and 1043 
Bafilomycin A1 at 0, 2 and 48 hours post-infection (pi). The percentage (%) of 1044 
reduction in cell viability was assessed using a Live/Dead stain and analysed by 1045 
flow cytometry. Mean and SD shown. Experiments performed in triplicate in 2 1046 
independent donors 1047 
The effect of inhibitor LY294002 and Bafilomycin A1 on HIV-1 localisation in 1048 
MDDC. MDDC pre-treated with inhibitors were infected with HIV-1 for analysis 1049 
by confocal microscopy. Labelling of p24 Gag HIV-1 = green, nuclei = blue. Scale = 1050 
10 µM. 1051 
C) The effect of LY294002 and Bafilomycin A1 on LDL-DIL and HRP uptake into 1052 
MDDC. Inhibitors added overnight before the addition of LDL-DIL = green, and 1053 
HRP = red, nuclei blue. Scale = 10 µM. 1054 
 1055 
Figure 6. Endocytic trafficking is compromised in BIN1, RAB7L1 and RAB8A transfected 1056 
MDDC. 1057 
The effect of target siRNA on vesicle trafficking in MDDC.  1058 
 A) MDDC transfected with ARF1, BIN-1, Rab7L1 and RAB8A siRNA for 48 hours 1059 
were either labelled with either EEA1 for early endosomes (red, panel 1), or 1060 
incubated with Transferrin (green, panel 2), for 20 minutes 37°C or LDL-DIL 1061 
(green, panel 3) for 2 hours 37°C. Non-target siRNA was used a control. Nuclei 1062 
in Blue. Scale = 10 µM. 1063 
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B) Quantification of EEA1 vesicles in MDDC transfected with target siRNA 1064 
compared to non-target siRNA control (n = 150 cells). Mean and SEM from 1065 
three independent donors shown, * p < 0.05, *** p < 0.0005. 1066 
   C) Average EEA1 vesicle size (µM) in MDDC transfected with target siRNA 1067 
compared to non-target siRNA control (n = 150 cells). Mean and SEM from 1068 
three independent donors shown, *** p < 0.0005. 1069 
D) Quantification of the number of transferrin positive vesicles under each 1070 
condition compared to non-target control (n=150). Mean and SEM from three 1071 
independent donors shown. *p < 0.05. 1072 
E) Measurement of the intensity of Transferrin in transfected MDDC under each 1073 
condition compared to non-target control (n=150). Mean and SEM from three 1074 
independent donors shown.  *p < 0.05, **p < 0.005. 1075 
F) Quantitative analysis of LDL-DIL containing vesicles (n = 120). Mean and SEM 1076 
from three independent donors shown, * p < 0.05, *** p < 0.0005. 1077 
G) Intensity of LDL-DIL in transfected MDDC compared to non-target siRNA (n = 1078 
120). Mean and SEM from three independent donors shown, * p < 0.05. 1079 
 1080 
Figure 7.  HIV-1 trans-infection requires retromer recycling to the plasma membrane.  1081 
A-B)  The reduction in HIV-1 trans-infection between MDDC and CD4+ T-cells in 1082 
MDDC transfected with VPS26A and VPS35 via siRNA transfection. The 1083 
reduction in trans-infection is normalised to non-target siRNA for R9 (d) and R8-1084 
BAL (e). Mean ± SD is shown, n = 4. *p < 0.05, ***p < 0.0001. 1085 
C-D)  Western blots showing the knockdown of VPS26A and VPS35 in MDDC, 1086 
performed in triplicate, compared to untreated cell lysate and non-target siRNA 1087 
transfected MDDC. Actin used as a loading control. 1088 
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E) Quantification of protein knockdown of VPS26A and VPS35 in transfected 1089 
MDDC relative to non-target lane. All lanes compared to corresponding Actin 1090 
loading control (black bars). Mean and ± SD shown, n = 3. 1091 
 1092 
Figure 8 Model for the roles of ARF1, BIN1, RAB7L1 and RAB8A in the endocytic pathway 1093 
and vesicle formation in MDDC. 1094 
Molecules are internalised from the cell surface via endocytic vesicles that fuse with each 1095 
other or existing endocytic vesicles to form early endosomes.  The budding of vesicles 1096 
containing cargo from early endosomes to the plasma membrane and trans-Golgi network 1097 
(TGN) requires the activity of BIN1.  TGN vesicles bud from the TGN surface and either fuse 1098 
with each other or endocytic compartments. The TGN is responsible for sorting receptors 1099 
from degradative compartments and delivers newly synthesised lysosomal enzymes in the 1100 
form of lysosomal hydrolase via the mannose-6-phosphate receptor. Both transferrin and 1101 
LDL are taken into the cell via clathrin-receptor mediated endocytosis. Transferrin and its 1102 
receptor are recycled from early endosomes back to the plasma membrane. LDL is trafficked 1103 
directly to lysosomes prior to release into the cytoplasm. The dynamic retrograde transport 1104 
of vesicles between the TGN and endocytic compartment and the plasma membrane via the 1105 
retromer and other trafficking pathways required depends on the activity of ARF1, RAB7L1 1106 
and RAB8A.  HIV-1 trans-infection between MDDC and CD4+ T-cells requires a homeostatic 1107 
balance of the endocytic pathway. By blocking trafficking of molecules between early 1108 
endosomes and the TGN and onward polarised transport of cargo to the plasma membrane, 1109 
HIV-1 trans-infection is inhibited. Depletion of targeted proteins results in the accumulation 1110 
of HIV-1 in intracellular vesicles that are unable to traffic to the virological synapse  1111 
 1112 
Table 1 1113 
Network analysis statistical data 1114 
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A) Statistical Data (p- and q-values) for biological processes of genes inhibitory to HIV-1 1115 
trans-infection. Values < 0.005 are displayed for each node name. The number of data sets 1116 
included in the process are indicated under the dataset size heading. 1117 
B) Statistical Data (p- and q-values) for biological processes of genes facilitating HIV-1 trans-1118 
infection. Values < 0.005 are displayed for each node name. The number of data sets 1119 
included in the process are indicated under the dataset size heading 1120 
C) Statistical Data (p- and q-values) for cellular compartments of genes inhibitory to HIV-1 1121 
trans-infection. Values < 0.005 are displayed for each node name. The numbers of data sets 1122 
associated with the cellular compartments are indicated under the dataset size heading. 1123 
D) Statistical Data (p- and q-values) for cellular compartments of genes facilitating HIV-1 1124 
trans-infection. Values < 0.005 are displayed for each node name. The numbers of data sets 1125 
included in the process are indicated under the dataset size heading. 1126 
 1127 
 1128 
 1129 
 1130 
 1131 
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Table 1 Network analysis statistical data 
 
A) Cellular Compartments– Facilitaing Genes 
Nodename pvalue qvalue Dataset size 
Cytoplasmic membrane-
bound vesicle 
1.781257032788977E-5 0.0026505776165784978 7 
Cytoplasmic vesicle 2.9736862512104874E-5 0.0022129769452692294 7 
Golgi apparatus 7.260275955618954E-5 0.0035995739100488366 7 
Clathrin-coated vesicles 1.1280567574068089E-4 0.004193431353399224 4 
Trans-Golgi network 1.5015004674908726E-4 0.004464810314555923 4 
B) Cellular Compartments– Inhibitory Genes 
Nodename pvalue qvalue Dataset size 
Clathrin coat of coated pit 1.98808829214536E-8 2.0278480239444008E-6 4 
Clathrin vesicle coat 7.728295638241832E-8 3.9414231596257565E-6 4 
Clathrin coat 5.75990999192209E-7 1.9583507854470383E-5 4 
Vesicle coat 6.170337924836827E-7 1.5734242778675522E-5 4 
Coated pit 1.8932548517714428E-6 3.86216897007019E-5 4 
C) Biological Processes – Facilitating Genes 
Nodename pvalue qvalue Dataset size 
Vesicle-mediated transport 2.5476631776993885E-7 1.4444208784170076E-4 8 
Membrane Orgainisation 7.045745098037326E-5 0.019777204754682143 6 
Endocytosis 1.3846610717114176E-4 0.025832390294862395 5 
Vesicle Organisation 2.614347913818171E-4 0.03638479278473983 4 
Cellular protein localisation 2.906708321191288E-4 0.03242937937435153 6 
D) Biological Processes – Inhibitory Genes 
Nodename pvalue qvalue Dataset size 
Vesicle-mediated Transport 2.60964598927977E-5 0.01146851519073222 6 
Endocytosis 3.158300588098925E-5 0.006955651219872405 5 
Receptor-mediated 
endocytosis 
1.0101208431475834E-4 0.0147729914135587 4 
Establishment of protein 
localisation 
1.375341659809643E-4 0.015083655172842936 6 
Protein localisation 3.4173910866504216E-4 0.02976299308721586 6 
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